Minaris regenerative medicine streamlining contract manufacturing with veeva vault quality suite applications

Global cdmo unifies quality content and training for greater visibility and agility pleasanton, calif. , may 24, 2023 /prnewswire/ -- veeva systems (nyse: veev) today announced that minaris regenerative medicine, a leading contract development and manufacturing organization (cdmo) focused on cell and gene therapies, selected veeva vault qualitydocs and veeva vault training to advance its global quality operations.
VEEV Ratings Summary
VEEV Quant Ranking